SureTrader SureTrader
Home > Boards > US OTC > Medical - Healthcare >

BioCorRx (BICX)

BICX RSS Feed
Add BICX Price Alert      Hide Sticky   Hide Intro
Moderator: Pip611
Search This Board:
Last Post: 9/28/2016 7:53:28 PM - Followers: 96 - Board type: Free - Posts Today: 0

 

 

About BioCorRx

Program Overview

BioCorRx (OTCBB: BICX) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a treatment program that is used by various licensed alcohol addiction clinics throughout the United States.

The program consists of two components:BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol for as long as a year in some patients, depending on individual metabolism rates.BioCorRx also owns a life coaching program that is tailored specifically to alcoholics. Once a patient has received the implant, they are encouraged to enter the life coaching program to maximize results.

BioCorRx’s revolutionary alcohol treatment program has an 85% success rate as reported by patients in routine telephone and face to face interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose.

Technology

Naltrexone is a medication that blocks the effects of drugs known as opioids and was approved by the FDA in 1995 for the treatment of alcohol dependence.

Learn more about the side effects of naltrexone.

Naltrexone blocks the parts of the brain that "feel pleasure” when patients use alcohol. When these areas of the brain are blocked, patients feel significantly less cravings for alcohol and even if alcohol is used, the effects of it will be extremely limited - making sobriety the only option. Once medical intervention has reduced the physical need for alcohol, the program goes on to address the patient's psychological needs. The combination of these treatments has resulted in the highest chance of sobriety.

naltrexone implant

While other companies use naltrexone in their treatments, the drug is typically administered in oral or injection form, requiring their patients to be responsible for taking the medication or scheduling an appointment.

While some patients do well with the oral formulation, there is a drawback that it must be taken daily and a patient whose craving becomes overwhelming can obtain the euphoria simply by skipping a dose before resuming abuse. Patients who received the program developed by BioCorRx are treated with a slow release dose that can last up to year in many patients (depending on various factors such as metabolism rates), which gives the patients a higher success rate for the treatment of alcoholism.

The outpatient naltrexone implant procedure can take as little as 20 minutes under local anesthetic in some cases. Most patients can return to work or their daily routine in the same day, without the cravings for alcohol.

Mission, Vision, Values

Mission

BioCorRx is focused on providing leadership and innovation for the treatment of alcoholism by offering a high-quality, comprehensive and cost-effective recovery program that allows patients and their loved ones to celebrate freedom from the cycle of alcohol addiction. Our program is built on a strong foundation of experience and practice, allowing for an improved quality of life for recovering alcoholics.

Vision

BioCorRx strives to be the preeminent, long-term alcohol recovery program used by treatment centers around the world for alcoholics, as well as their family and friends. By providing patients a "Fresh Start" on life, they have the opportunity to live happier, healthier, more productive lives away from the damaging impact of alcohol. We have built an organization that is committed to nurturing research for cutting-edge alcohol recovery technologies and integrating those technologies with comprehensive alcohol recovery treatment programs.

Values

BioCorRx provides the opportunity and tools to treatment centers so they can help patients live happier, healthier, and more productive lives to those suffering from alcohol addiction (as well as their family and friends) by helping them break the addiction cycle and live alcohol-free. We want patients to celebrate freedom from the past and hope for the future. Our team consists of physicians, coaches, founders and management that are committed to providing high-quality services and adherence to ethical care.

Our goal is to give our treatment center partners the ability to deliver our program in a timely, warm and compassionate way to give patients, as well as their families and friends, peace of mind. To achieve this, BioCorRx has built its program around highly-qualified alcohol addiction specialists and effective treatment solutions.

We are committed to quality and continuous improvement in order to meet our partners’ needs for an individualized program dedicated to alcohol addiction recovery.

Investors Overview

BioCorRx is uniquely poised to gain significant market share of the $22 billion annual alcohol treatment market in the US.

More than 7% of the US population ages 18 years and older or 13.8 million Americans have problems with drinking, including 8.1 million people who suffer from alcoholism. And the costs financially are staggering. Alcohol dependency and abuse costs the US over $220 billion a year. For the sake of comparison, this is greater than the amount of money spent to combat cancer ($196 billion) and obesity ($133 billion).

BioCorRx intends to distribute the program to a new clinic in the United States every 60 to 90 days. Clinics using our program are also holding discussions with major health insurance providers to pay for all or a portion of the treatment fees.

Business Model

BioCorRx’s research has discovered that demand for its services are high and that growth in highly marketed segments of the population may be achieved through partnering with additional clinic sites. The company is also exploring the sub-licensing of the program to select regions of the US and internationally.

BioCorRx's goal is to meet its growth targets through licensing opportunities by promoting its naltrexone implant product and counseling service model to existing medical clinics and treatment centers that will purchase the program and/or product from the company. In addition, Fresh Start Private intends to open corporately owned clinics in select key markets where it is deemed appropriate.

Stock Price & Charts

BioCorRx is a fully reporting company. Financial reports and other reports are available for view or by visiting the OTCBB.com online website. Audited financial reports are available quarterly.

Company Structure Details

  • Legal name: BioCorRx
    Sector: Healthcare
    Industry: Specialized Health Services
    Full Time Employees: 4
    Public Company: SEC Reporting and fully audited
    Symbol: BICX
    Exchange: OTCBB
    Outstanding: 117,800,000
    Authorized: 200,000,000
    CUSIP: 35804J102
    NAICS Code: 623220
    SIC Number: 8093
    Transfer Agent: Columbia Stock Transfer Company, 1869 E. Seltice Way #292, Post Falls, ID 83854 Tel (208) 664-3544
    CIK: 0001443863
    EIN: 26-1972677
    Year End: December 31
    State of incorporation: Nevada
    Products: Alcohol rehabilitation, exclusive naltrexone implant technology
    Address: 601 North Parkcenter Drive, Suite 103, Santa Ana, CA 92705 USA
    Investors: 858-381-4677
    Email: investors@biocorrx.com
    Website: www.biocorrx.com
Watch Jeremy Miller on Fox News!
https://www.youtube.com/watch?v=kVKgWi3_t5Y

<iframe width="560" height="315" src="; frameborder="0" allowfullscreen></iframe>www.youtube.com/embed/xhJrYqsV0VQ

<iframe width="560" height="315" src="https://www.youtube.com/watch?v=kVKgWi3_t5Y" frameborder="0" allowfullscreen></iframe>


 

BICX Chart

Key Executives

Kent Emry - CEO, Director
Brady Granier -COO, Director
Lourdes Felix -CFO, Director
Dr. Jorge Andrade, Jr. - Director
Neil Muller -Co-Founder and President, Director 

Locations
Locations of independently owned clinics using our Fresh Start Program

Start Fresh Recovery
720 N. Tustin Ave.
Suite 206
Santa Ana, CA 92705
714-541-6100
800-916-1099
www.startfreshrecovery.com 
www.stopdrinkingUSA.com

Start Fresh Executive Recovery
367 E Virginia Ave
Phoenix, AZ 85004
855-393-HOPE (4673)
www.ExecutiveRecovery.net 

Fresh Start Private Florida
1415 Panther Lane
Suites 313-320
Naples, FL 34109
800-985-7574
www.FreshStartPrivateFlorida.com 

Start Fresh Alcohol Recovery Center
2827 S. 88th St
Omaha NE 68124
402-884-1221
www.startfreshNE.com

Coming Soon!

• San Francisco, California
• Chandler, Arizona
• North Scottsdale, Arizona
• Connecticut

Insider Interview Links

December 2, 2013 - thewallstreetanalyzer.com Interview with Brady Granier COO
November 14, 2013 - SmallCapVoice Interview with Kent Emry CEO
October 2, 2013 - SmallCapVoice Interview with Brady Granier COO

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BICX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#7544  Sticky Note VIVITROL is injectable naltrexone produced by Alkermes plc Pip611 09/09/16 05:15:47 PM
#7563   Thanks, forgot that for a senior moment. Fido 09/28/16 07:53:28 PM
#7562   That was the implant and this is the Pip611 09/28/16 04:18:56 PM
#7561   Isn't that the market they have been trying Fido 09/28/16 03:12:46 PM
#7560   Huge market here for injectable naltrexone Pip611 09/26/16 03:09:18 PM
#7559   Webcast - BioCorRx Inc. Singular Research 11th Annual Pip611 09/23/16 02:14:01 PM
#7558   I have a feeling we're going to be Pip611 09/23/16 06:00:44 AM
#7557   Nice little move today, hopefully something big tomorrow ! JB51 09/21/16 03:03:14 PM
#7556   BioCorRx Inc. to Present at the Singular Research Pip611 09/19/16 07:56:15 PM
#7555   News out doing conference in California JB51 09/19/16 06:03:53 PM
#7554   No news, but some nice bids and it Pip611 09/19/16 03:10:58 PM
#7553   Big buys coming in !! Any news ? DREAM BIG 09/19/16 02:44:26 PM
#7552   After animal studies will there need to be big orange 09/15/16 06:17:29 PM
#7551   Agree, positive developments for sure. I've been Fido 09/15/16 10:06:11 AM
#7550   On the road to FDA approval for an Pip611 09/15/16 08:51:12 AM
#7549   Nice to see a plan going forward but Fido 09/15/16 08:35:05 AM
#7548   BioCorRx Inc. Announces Update From First Joint Steering Pip611 09/15/16 08:07:34 AM
#7547   Bids are building up and no sellers so Pip611 09/14/16 08:46:09 PM
#7546   Nice 340K bid @ .04 - investors are Pip611 09/12/16 11:42:15 AM
#7545   Possibly no one knows-but how would BICX go big orange 09/10/16 12:14:14 PM
#7544   VIVITROL is injectable naltrexone produced by Alkermes plc Pip611 09/09/16 05:15:47 PM
#7543   Bid is building again. We just need to Pip611 09/09/16 12:48:08 PM
#7542   Looks like you were right ! Entrepreneur2 09/06/16 02:40:19 PM
#7541   bids are starting to build up again.... Pip611 09/06/16 02:00:04 PM
#7540   Hopefully the seller is gone this week and Pip611 09/06/16 07:54:50 AM
#7539   BioCorRX NEWS OUT! Entrepreneur2 08/31/16 10:03:41 PM
#7538   Wake up BiocorRx !!! DREAM BIG 08/31/16 03:29:54 PM
#7537   I agree with that assessment. I think Fido 08/25/16 01:18:30 PM
#7536   BICX bullish 0.04 stocktrademan 08/25/16 12:01:41 PM
#7535   Hope everybody was able to get in on Pip611 08/25/16 07:20:07 AM
#7534   Sometimes people just put a market order in Pip611 08/24/16 03:36:53 PM
#7533   Can't understand at .03 what's the use of JB51 08/24/16 03:32:32 PM
#7532   Seller dumped into the bid and crashed the Pip611 08/24/16 03:10:37 PM
#7531   Now what's driving it down? JB51 08/24/16 02:59:24 PM
#7530   Great find dream. The bid is really starting Pip611 08/23/16 02:03:38 PM
#7529   Some good buys flowing !! DREAM BIG 08/23/16 11:38:49 AM
#7528   http://content.stockpr.com/mzgroup/files/pages/mz-news/MZ+Newsletter+-+Summer+20 DREAM BIG 08/22/16 04:15:53 PM
#7527   That's probably why they are going for the Pip611 08/21/16 08:47:41 PM
#7526   The really down side to the 10-Q was big orange 08/21/16 07:24:18 PM
#7525   Been here for years and have seen this Fido 08/19/16 05:49:45 AM
#7524   They are doing an excellent job executing recently. botlow 08/19/16 01:09:09 AM
#7523   Expecting a good jump in price tomorrow .. !! DREAM BIG 08/18/16 09:09:54 PM
#7522   5mm in the wallet and ready to go. Pip611 08/18/16 09:07:51 PM
#7521   With a new relationship and the 10-Q out Fido 08/17/16 03:26:25 PM
#7520   Hey Fido !! Same boat here buddy !!! DREAM BIG 08/17/16 03:17:34 PM
#7519   Well yippee for "Not Bad". :) Fido 08/17/16 03:11:41 PM
#7518   10-Q out !!! Not bad Quarterly Report (10-q) Source: DREAM BIG 08/17/16 02:30:21 PM
#7517   Fingers crossed, can only hope so.... JB51 08/17/16 01:57:58 PM
#7516   The company is going in a new direction Pip611 08/17/16 01:17:42 PM
#7515   How many consults do we need? Haven't seen JB51 08/17/16 01:14:37 PM
#7514   Smells like FDA approval of injectable Neltrexone to me-- Pip611 08/17/16 12:25:27 PM
PostSubject